Mobius Life Sciences
Home
About
Investment Criteria
Portfolio
News & Events
Reports
Contact
Portfolio
Mobius Life Sciences' Investments
CompanDX
CompanDX holds the key to value generation in the exciting new field of Personalised Medicine....
Keep Reading...
Xenogesis
XenoGesis Ltd. is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism &...
Keep Reading...
Cellaura Technologies
CellAura Technologies is the premier source of innovative fluorescent screening products for life science research...
Keep Reading...
Haemostatix
Haemostatix is developing first-in-class clotting agents for the treatment of bleeding or ‘haemostasis’. The company...
Keep Reading...
R5 Pharmaceuticals
BioCity Nottingham also invested in R5 Pharmaceuticals and the company was subsequently sold
© Mobius Life Sciences 2013
Web site design by
OLIK